A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma.

Autor: Qi X; Department of Surgery, The University of Hong Kong, Hong Kong, China., Wong BL; New β Innovation Limited, 18/F Chevalier Commercial Centre, Hong Kong, China., Lau SH; New β Innovation Limited, 18/F Chevalier Commercial Centre, Hong Kong, China., Ng KT; Department of Surgery, The University of Hong Kong, Hong Kong, China., Kwok SY; New β Innovation Limited, 18/F Chevalier Commercial Centre, Hong Kong, China., Kin-Wai Sun C; New β Innovation Limited, 18/F Chevalier Commercial Centre, Hong Kong, China., Tzang FC; New β Innovation Limited, 18/F Chevalier Commercial Centre, Hong Kong, China., Shao Y; Department of Surgery, The University of Hong Kong, Hong Kong, China., Li CX; Department of Surgery, The University of Hong Kong, Hong Kong, China., Geng W; Department of Surgery, The University of Hong Kong, Hong Kong, China., Ling CC; Department of Surgery, The University of Hong Kong, Hong Kong, China., Ma YY; Department of Surgery, The University of Hong Kong, Hong Kong, China., Liu XB; Department of Surgery, The University of Hong Kong, Hong Kong, China., Liu H; Department of Surgery, The University of Hong Kong, Hong Kong, China., Liu J; Department of Surgery, The University of Hong Kong, Hong Kong, China., Yeung WH; Department of Surgery, The University of Hong Kong, Hong Kong, China., Lo CM; Department of Surgery, The University of Hong Kong, Hong Kong, China.; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China., Man K; Department of Surgery, The University of Hong Kong, Hong Kong, China.; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.

Publikováno v: Oncotarget [Oncotarget] 2017 Jul 28; Vol. 8 (49), pp. 85311-85325. Date of Electronic Publication: 2017 Jul 28 (Print Publication: 2017).